| 000 | 00772 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250512003835.0 | ||
| 264 | 0 | _c19891114 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0001-5792 | ||
| 024 | 7 |
_a10.1159/000205305 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOzsoylu, S | |
| 245 | 0 | 0 |
_aIntravenous methylprednisolone for myelofibrosis. _h[electronic resource] |
| 260 |
_bActa haematologica _c1989 |
||
| 300 |
_a109 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
| 773 | 0 |
_tActa haematologica _gvol. 82 _gno. 2 _gp. 109 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000205305 _zAvailable from publisher's website |
| 999 |
_c2514389 _d2514389 |
||